EUVIMEDEUVIMED entdecken
Crossref

Association of zinc transporter expression with clinicopathological features and prognosis in patients with breast cancer

Yukari Nagasaki, Tatsushi Shiomi, Fumiaki Sanuki, Yuka Mikami, Hirotake Nishimura, Takashi Akiyama, Tsunehisa Nomura, Naruto Taira, Takuya Moriya

Medical Molecular Morphology · 07.08.2026

DOI: 10.1007/s00795-026-00472-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Molecular Morphology, online erschienen am 07.08.2026. Verfasst von Yukari Nagasaki und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama, 701-0192, Japan. yusica7.arrows@gmail.com. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Kawasaki Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zinc transporters, including ZIP6 (SLC39A6, also known as LIV-1) and ZIP10 (SLC39A10), are reportedly involved in breast cancer progression and metastasis. We aimed to clarify the association of the expression of zinc transporters with clinicopathological features and prognosis in breast cancer. We retrospectively included 200 patients who underwent surgery for invasive ductal carcinoma of the breast (invasive diameter ≥ 10 mm) at our institution between January 1, 2010 and June 30, 2023. Immunohistochemical staining for ZIP6 and ZIP10 was performed, and their expression levels were evaluated. Survival analyses were performed by stratifying patients into four groups based on combined ZIP6 and ZIP10 expression (high/low). We found that the expression levels of ZIP6 and ZIP10 showed a statistically significant positive correlation. Low ZIP6 expression was associated with aggressive clinicopathological features, including a higher Ki-67 labeling index, higher histological grade, and larger tumor size. Although survival differences did not reach statistical significance, combined evaluation of ZIP6 and ZIP10 expression revealed distinct survival tendencies among the expression groups. These findings suggest that combined assessment of ZIP6 and ZIP10 expression may provide additional prognostic information beyond ZIP6 expression alone. Future studies with larger cohorts and longer follow-up are warranted to validate these findings.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerPrognosisZIP10ZIP6 (SLC39A6/LIV-1)Zinc transporter

Autor:innen und Institutionen

  • Department of Pathology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama, 701-0192, Japan. yusica7.arrows@gmail.com.
  • Department of Pathology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama, 701-0192, Japan.
  • Department of Breast and Thyroid Surgery, Kawasaki Medical School, Okayama, Japan.

Förderung

  • Kawasaki Medical School

Zitieren

APA

Nagasaki, Y., Shiomi, T., Sanuki, F., Mikami, Y., Nishimura, H., Akiyama, T., Nomura, T., Taira, N., & Moriya, T. (2026). Association of zinc transporter expression with clinicopathological features and prognosis in patients with breast cancer. Medical Molecular Morphology. https://doi.org/10.1007/s00795-026-00472-4

Vancouver

Nagasaki Y, Shiomi T, Sanuki F, Mikami Y, Nishimura H, Akiyama T, et al. Association of zinc transporter expression with clinicopathological features and prognosis in patients with breast cancer. Medical Molecular Morphology. 2026. doi:10.1007/s00795-026-00472-4

BibTeX
@article{Nagasaki2026,
  author = {Nagasaki, Yukari and Shiomi, Tatsushi and Sanuki, Fumiaki and Mikami, Yuka and Nishimura, Hirotake and Akiyama, Takashi and Nomura, Tsunehisa and Taira, Naruto and Moriya, Takuya},
  title = {Association of zinc transporter expression with clinicopathological features and prognosis in patients with breast cancer},
  journal = {Medical Molecular Morphology},
  year = {2026},
  doi = {10.1007/s00795-026-00472-4}
}
Kostenlos starten →